ライブラリ登録: Guest
International Journal of Medicinal Mushrooms

年間 12 号発行

ISSN 印刷: 1521-9437

ISSN オンライン: 1940-4344

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years. 2017 Journal Citation Reports (Clarivate Analytics, 2018) IF: 1.2 To calculate the five year Impact Factor, citations are counted in 2017 to the previous five years and divided by the source items published in the previous five years. 2017 Journal Citation Reports (Clarivate Analytics, 2018) 5-Year IF: 1.4 The Immediacy Index is the average number of times an article is cited in the year it is published. The journal Immediacy Index indicates how quickly articles in a journal are cited. Immediacy Index: 0.3 The Eigenfactor score, developed by Jevin West and Carl Bergstrom at the University of Washington, is a rating of the total importance of a scientific journal. Journals are rated according to the number of incoming citations, with citations from highly ranked journals weighted to make a larger contribution to the eigenfactor than those from poorly ranked journals. Eigenfactor: 0.00066 The Journal Citation Indicator (JCI) is a single measurement of the field-normalized citation impact of journals in the Web of Science Core Collection across disciplines. The key words here are that the metric is normalized and cross-disciplinary. JCI: 0.34 SJR: 0.274 SNIP: 0.41 CiteScore™:: 2.8 H-Index: 37

Indexed in

Dietary Supplements from Culinary-Medicinal Mushrooms: A Variety of Regulations and Safety Concerns for the 21st Century

巻 6, 発行 3, 2004, 18 pages
DOI: 10.1615/IntJMedMushr.v6.i3.30
Get accessGet access

要約

In the second half of the 20th Century, mushroom producing technologies grew enormously. Mushrooms represent a valuable source of bioactive agents with potent and unique medicinal properties. Many of them are not strictly pharmaceutical products (real medicines) but represent a novel class of dietary supplements (DSs) or "mushroom nutriceuticals." The agents derived from medicinal mushroom fruit bodies, cultured mycelium, and/or culture filtrates exert a wide range of beneficial biological effects when tested in vitro or using animal models. Recent years have seen a surge of commercial interest in medicinal mushroom DSs, the common market value of which is approximately $9 billion US dollars. The safety advantages of using mushroom-based DSs, as opposed to herbal preparations are: (1) The overwhelming majority of mushrooms used for production of DSs are cultivated commercially (and not gathered in the wild); this provides very good chances of proper identification, pre- and unadulterated products. In many cases it also means genetic uniformity. (2) Mushrooms are easily propagated vegetatively, and thus keep to one clone. The mycelium can be stored for a long time, and the genetic and biochemical consistency may be checked after considerable time. (3) The main advantage, in our opinion, is that many mushrooms are capable of growing in the form of mycelial biomass in submerged cultures. In this article, we discuss legal and regulatory issues up to 2004 introducing and controlling DSs from medicinal mushrooms in different countries, including the United States, the European Community (EU), Canada, Australia, New Zealand, Japan, and Israel, as well as the guidelines of the World Health Organization. A lot of attention is drawn to the safety and diversity of DS types from culinary-medicinal mushrooms. We hope that these and future regulations will continue to provide and protect stable medicinal mushroom products of reliable quality and that culturing biotechnology will continue to be the best and the most progressive technique for obtaining consistent and safe mushroom products.

によって引用された
  1. Liang Yi, Chen Yijie, Liu Honghong, Luan Rong, Che Tao, Jiang Shuai, Xie Dongyang, Sun Hui, The tumor rejection effect of protein components from medicinal fungus, Biomedicine & Preventive Nutrition, 1, 4, 2011. Crossref

  2. Llauradó Gabriel, Morris Humberto J., Lebeque Yamila, Gutiérrez Adrián, Fontaine Roberto, Bermúdez Rosa C., Perraud-Gaime Isabelle, Phytochemical screening and effects on cell-mediated immune response ofPleurotusfruiting bodies powder, Food and Agricultural Immunology, 24, 3, 2013. Crossref

  3. Jayasuriya W. J. A. Banukie N., Wanigatunge Chandanie A., Fernando Gita H., Abeytunga D. Thusitha U., Suresh T. Sugandhika, Hypoglycaemic Activity of CulinaryPleurotus ostreatusandP.cystidiosusMushrooms in Healthy Volunteers and Type 2 Diabetic Patients on Diet Control and the Possible Mechanisms of Action, Phytotherapy Research, 29, 2, 2015. Crossref

Begell Digital Portal Begellデジタルライブラリー 電子書籍 ジャーナル 参考文献と会報 リサーチ集 価格及び購読のポリシー Begell House 連絡先 Language English 中文 Русский Português German French Spain